Skip to main content

Table 1 VD status of PMO patients who received ALN/D5600 combination treatment throughout the 12-month study period (n = 96)

From: Calcifediol (25-hydroxyvitamin D) improvement and calcium-phosphate metabolism of alendronate sodium/vitamin D3 combination in Chinese women with postmenopausal osteoporosis: a post hoc efficacy analysis and safety reappraisal

Percenta

Baseline

3 months

6 months

9 months

12 months

VD insufficiency

89.6

65.6

47.9

33.4

43.8

VD deficiency

54.2

11.5

5.2

3.1

4.2

  1. aVitamin D insufficiency was defined as serum 25(OH) D < 30 ng/mL; vitamin D deficiency was defined as serum 25(OH) D < 20 ng/mL; Test for trend P-values < 0.001 for VD insufficiency and deficiency using the Cochran-Armitage trend test